FDA Grants Priority Review for Arikayce Inhaled Antibiotic for MAC
The FDA accepted Insmed's supplemental new drug application with Priority Review for Arikayce to treat Mycobacterium avium complex (MAC) lung disease.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Semaglutide Tied to Fewer Asthma, COPD Exacerbations
The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
Recall for GE Healthcare Patient Monitoring System
GE HealthCare has issued updated use instructions for Portrait Mobile Monitoring Solutions devices operating on certain versions of Portrait Core Services software, according to an FDA alert.
Pharmaceuticals
Latest
Merck Wants to Extend RSV Vaccine to Second Season
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
Diagnostics & Testing
Latest
Increasing Use of Oscillometry for Lung Testing
A national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
Monitoring & Treatment
Latest
Early Alert for NOxBox Nitric Oxide Delivery System
NOxBox reported complaints of oxygen leaks due to failure of the oxygen tubing or tubing connection within the NOxMixer module of the NOxBoxi device, according to the FDA.